{"id":"tp-44780","type":"article-newspaper","title":"enVVeno Medical Posts $6.29 Q3 Loss Per Share, Targets Year-End Enrollment","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/44780","datePublished":"2026-10-30T14:31:07.000Z","dateModified":"2026-10-30T14:31:07.000Z","language":"en","abstract":"The company expects its first TAVVE study patient before the end of 2026. The initial stage is expected to include up to 10 patients.","section":"Business","references":[]}